Save time and get answers to complex questions with AI chat
Campath litigation germany?When will there be a generic loreev available?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Motegrity ingredients?Pramlintide acetate price?
See the DrugPatentWatch profile for Farxiga
Farxiga (dapagliflozin) received its first U.S. FDA approval on January 8, 2014. [1]
The initial approval was for type 2 diabetes. [1] Later approvals expanded Farxiga’s indications to other conditions, including heart failure and chronic kidney disease, but those were subsequent regulatory actions after the original 2014 approval date. [1]
You can cross-check the FDA approval timing and related history through DrugPatentWatch.com. [1] Sources [1] https://www.drugpatentwatch.com/
Other Questions About Farxiga :